Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence Approach
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology USA
    Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Advancing Genomic Competence and Patient Centered Care in Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom
    AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management
    Release Date:
    Review Process: Pfizer Internal
    Research Internal Medicine Australia, Canada, Germany, Greece, Japan, Korea, Taiwan
    Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-posit
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology United States Minor Outlying I
    OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic Malignancies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory Outcome
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Implementing Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Pfizer Internal
    Fellowship Internal Medicine Germany
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Support for the Professions Senegal
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China
    Improving cancer care in patients with metastatic breast cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation:(link)
    Translation:(link)
    Quality Improvement Oncology Kazakhstan
    An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Inflammation & Immunology All
    Improving Health Equity in IBD through Disparities Research
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Emerging Science in the Management of Acute Myeloid Leukemia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Addressing Systemic Drivers of Racial Health Inequities
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Health Equity USA
    Diversity in Postmarketing Drug Safety Surveillance
    Release Date:
    Review Process: Pfizer Internal
    Research Patient Safety USA
    Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient Education
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Ghana, Rwanda
    Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-Pacific
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
    2023 Inflammatory Bowel Disease (IBD) Fellowship – India
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology India